Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

iShares iBonds Dec 2030 Term Corporate ETF (IBDV)

21.36   0 (0%) 06-26 18:57
Open: 21.37 Pre. Close: 21.36
High: 21.4824 Low: 21.36
Volume: 26,282 Market Cap: 0(M)
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities. The underlying index consists of U.S. dollar-denominated, investment-grade securities issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion. It is non-diversified.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 21.51 - 21.63 21.63 - 21.74
Low: 21.09 - 21.23 21.23 - 21.35
Close: 21.16 - 21.38 21.38 - 21.58

Technical analysis

as of: 2022-06-24 4:40:42 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 25.41     One year: 26.05
Support: Support1: 20.86    Support2: 17.35
Resistance: Resistance1: 21.75    Resistance2: 22.3
Pivot: 21.36
Moving Average: MA(5): 21.27     MA(20): 21.52
MA(100): 22.56     MA(250): 24.17
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 43.7     %D(3): 36
RSI: RSI(14): 43
52-week: High: 26.25  Low: 20.86
Average Vol(K): 3-Month: 99 (K)  10-Days: 33 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IBDV ] has closed above bottom band by 49.3%. Bollinger Bands are 35.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 23 Mar 2022
Identification of Chicken CD44 as a Novel B Lymphocyte Receptor for Infectious Bursal Disease Virus | Journal of Virology - American Society for Microbiology

Tue, 01 Mar 2022
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality - Cureus

Wed, 16 Feb 2022
High mortality rates in IBDV explained - Poultry World

Wed, 09 Feb 2022
Birnaviridae Virus Factories Show Features of Liquid-Liquid Phase Separation and Are Distinct from Paracrystalline Arrays of Virions Observed by Electron Microscopy | Journal of Virology - American Society for Microbiology

Wed, 22 Sep 2021
Gumboro control in the field - Poultry World

Wed, 21 Jul 2021
Consistency and reliability of the IBD Immune-Complex Vaccine - The Poultry Site

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Technology
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 0 (%)
% Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.